Where next for the Danish adventure?

Investments in the pharmaceutical and biotechnology sectors have traditionally dominated the Danish venture market, until last year when investments dropped by nearly 50%. The sectors are both capital- and knowledge intensive. How will these fare in the current environment?

While the DVCA calls for a growth package to the venture industry, the biotech and pharma start-ups trim their organsiations to prepare for a tough year ahead. Read more in our Denmark focus, pages 16-19.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Industry
• Nordics